Drug Profile
Research programme: selective androgen receptor modulators - Endoceutics
Alternative Names: EM 8420Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Endoceutics
- Class
- Mechanism of Action Selective androgen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Osteoporosis; Sarcopenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoporosis in Canada
- 16 Jul 2016 No recent reports of development identified for preclinical development in Sarcopenia in Canada
- 09 May 2007 Preclinical trials in Osteoporosis in Canada (unspecified route)